رجوع
نطاق اليوم
KWD 14.40
KWD 14.41
نطاق 52 أسبوعًا
KWD 5.51
KWD 14.43
حجم التداول
3,099,217
متوسط 50 يوم / 200 يوم
KWD 14.33
/
KWD 9.82
الإغلاق السابق
KWD 14.42
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -166.9 | 0.3 |
| P/B | 16.5 | 2.9 |
| ROE % | -11.6 | 3.7 |
| Net Margin % | -4.3 | 3.8 |
| Rev Growth 5Y % | 20.0 | 10.0 |
| D/E | 1.8 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 14.500
+0.6%
مكرر الربحية المستقبلي
47.6
ربحية السهم المستقبلية
KWD 0.303
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
750 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.670
KWD 1.621 – KWD 1.721
|
1.5 B | 2 |
| FY2029 |
KWD 1.360
KWD 1.320 – KWD 1.402
|
1.3 B | 2 |
| FY2028 |
KWD 0.913
KWD 0.755 – KWD 1.052
|
1.1 B | 4 |
النقاط الرئيسية
Revenue grew 20.03% annually over 5 years — strong growth
Generating 29.85M in free cash flow
Capital efficient — spends only 0.52% of revenue on capex
ROIC of 3.41% — low return on invested capital
Interest coverage of 0.75× — tight debt servicing
النمو
Revenue Growth (5Y)
20.03%
Revenue (1Y)20.05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-11.58%
ROIC3.41%
Net Margin-4.27%
Op. Margin5.44%
الأمان
Debt / Equity
1.76
Current Ratio2.84
Interest Coverage0.75
التقييم
P/E Ratio
-166.90
P/B Ratio16.50
EV/EBITDA138.99
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20.05% | Revenue Growth (3Y) | 26.02% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 20.03% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 634.21M | Net Income (TTM) | -27.11M |
| ROE | -11.58% | ROA | -2.85% |
| Gross Margin | 87.32% | Operating Margin | 5.44% |
| Net Margin | -4.27% | Free Cash Flow (TTM) | 29.85M |
| ROIC | 3.41% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.76 | Current Ratio | 2.84 |
| Interest Coverage | 0.75 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -166.90 | P/B Ratio | 16.50 |
| P/S Ratio | 7.13 | PEG Ratio | 3.17 |
| EV/EBITDA | 138.99 | Dividend Yield | 0.00% |
| Market Cap | 4.52B | Enterprise Value | 4.79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 634.21M | 528.30M | 399.36M | 329.23M | 305.51M |
| Net Income | -27.11M | -56.11M | -151.58M | -236.57M | -250.46M |
| EPS (Diluted) | -0.09 | -0.18 | -0.51 | -0.82 | -0.92 |
| Gross Profit | 553.82M | 475.35M | 362.03M | 290.63M | 271.05M |
| Operating Income | 34.49M | 24.88M | -77.21M | -212.12M | -206.43M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 949.87M | 785.03M | 777.88M | 724.17M | 905.14M |
| Total Liabilities | 675.63M | 590.99M | 617.71M | 601.12M | 597.77M |
| Shareholders' Equity | 274.24M | 194.05M | 160.17M | 123.05M | 307.37M |
| Total Debt | 483.33M | 443.64M | 445.06M | 452.12M | 440.13M |
| Cash & Equivalents | 214.01M | 213.75M | 246.99M | 148.81M | 245.20M |
| Current Assets | 676.17M | 504.74M | 483.06M | 423.82M | 596.83M |
| Current Liabilities | 237.83M | 148.70M | 167.69M | 139.02M | 145.98M |